Physician profile
Daniel Blaize Noel
NPI 1396151882
$1,485.40
in general payments reported to CMS, 2019-2025
22 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $110 · 2021: $165 · 2022: $213 · 2023: $85.46 · 2024: $204 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $363.65 | 2019 | |
| Optinose US, INC. | $161.73 | 2019-2022 | |
| Aerin Medical INC. | $115.29 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $113.48 | 2019-2022 | |
| Glaxosmithkline, LLC. | $110.12 | 2021-2025 | Nucala |
| Genzyme Corporation | $103.84 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2022 | |
| Harmony Biosciences LLC | $83.12 | 2021-2023 | Wakix |
| Integra Lifesciences Corporation | $59.92 | 2024 | Codman Isocool Aht, Microfrance, Integra |
| Hill Dermaceuticals, INC. | $57.32 | 2024 | Tolak |
| Abbvie INC. | $30.88 | 2021 | |
| Stryker Corporation | $22.39 | 2023 | Audion Et Dilation System |
| Medtronic, INC. | $21.76 | 2021 | |
| Cochlear Americas | $19.63 | 2019 | |
| Axsome Therapeutics, INC. | $18.58 | 2023 | Sunosi |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $17.87 | 2019 | |
| Medtronic USA, INC. | $17.22 | 2020 | |
| Olympus America INC. | $16.50 | 2019 | |
| Alk-Abello, INC | $15.00 | 2020 | |
| Novo Nordisk INC | $13.48 | 2024 | Wegovy |
| Novartis Pharmaceuticals Corporation | $12.53 | 2021 | |
| Intersect Ent, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Noel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.